Noboru Hagino

Noboru Hagino

Auto-generated profile, based on publicly available information

Noboru Hagino

Division of Hematology and Rheumatology, Teikyo University Chiba Medical Center, Ichihara, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in American Journal of Nephrology
Verified
Journal Article
Closed access
PDF file
ASAkihiro N/A Shiroshita
Akihiro N/A Shiroshita
YOYasuhiro Oda
Yasuhiro Oda
STSeiji Takenouchi
Seiji Takenouchi
NHNoboru Hagino
Noboru Hagino
Yuki KataokaYuki Kataoka
Yuki Kataoka
Background: The sensitivity and specificity of anti-glomerular basement membrane (GBM) antibodies have not been systematically analyzed. In this systematic review, we aimed to evaluate the diagnostic accuracy of anti-GBM antibodies for anti-GBM disease. Summary: Potential studies were searched using MEDLINE, Embase, the Cochrane Library, and the International Clinical Trials Registry Platform based on the index test and target condition. The inclusion criteria were prospective or retrospective cohort studies or case-control studies assessing the sensitivity and specificity of anti-GBM antibodies, and the reference standard was clinical diagnosis including biopsy results. The exclusion criteria were review articles, case reports, animal studies, and in vitro studies. Quality assessment was conducted based on the Quality Assessment of Diagnostic Accuracy Studies-2. The pooled estimates of sensitivity and specificity were calculated using a bivariate random-effects model. The overall quality was evaluated using the Grades of Recommendation, Assessment, Development, and Evaluation. Six studies (1,691 patients) and 11 index tests were included in our systematic review. A high risk of bias and concerns regarding the applicability of patient selection were noted because of the case-control design in 67% of the included studies. The pooled sensitivity and specificity were 93% (95% CI: 84–97%) and 97% (95% CI: 94–99%), respectively. The certainty of evidence was low because of the high risk of bias and indirectness. Key Messages: Anti-GBM antibodies may exhibit high sensitivity and specificity in the diagnosis of anti-GBM disease. Further cohort studies are needed to confirm their precise diagnostic accuracy and compare diagnostic accuracies among different immunoassays.

1 October 2021 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
KNKeiji Nakamura
Keiji Nakamura
HNHidetoshi Nomoto
Hidetoshi Nomoto
SHSohei Harada
Sohei Harada
MSMasahiro Suzuki
Masahiro Suzuki
KYKeina Yomono
Keina Yomono
NONorio Ohmagari
Norio Ohmagari

23 May 2022 in Cureus
Verified
Journal Article
Open access
KNKen Nagahata
Ken Nagahata
SSShotaro Suzuki
Shotaro Suzuki
RYRitsuko Yokochi
Ritsuko Yokochi
YNYuichiro Nei
Yuichiro Nei
NHNoboru Hagino
Noboru Hagino
Optic perineuritis (OPN) is an intraorbital inflammatory disease that targets the optic nerve sheath, which can cause severe vision loss. OPN has been recently reported to be sometimes caused by myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD). MOGAD is rarely reported to be complicated with other autoimmune diseases. We report the first rare case of MOG-associated OPN complicated with granulomatous with polyangiitis (GPA). The vision loss, in this case, was initially considered to be caused by cavernous sinusitis in GPA. However, she was diagnosed with MOGAD with serial MRI findings and positive MOG antibody and had been successfully treated with glucocorticoid and tocilizumab for one and half years. This case emphasized the importance of evaluating the MOG antibody in a patient with recurrent OPN, complicated with vasculitis.

4 August 2023 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
KNKen Nagahata
Ken Nagahata
NHNoboru Hagino
Noboru Hagino

3 January 2024 in Clinical Rheumatology
Verified
Journal Article
Open access
PDF file
TSTatsunori Shizuku
Tatsunori Shizuku
NHNoboru Hagino
Noboru Hagino

1 March 2023 in Clinical Rheumatology
Verified
Journal Article
Open access
PDF file
KNKen Nagahata
Ken Nagahata
NHNoboru Hagino
Noboru Hagino